• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page


total joints

  1. Coronavirus Discussion - Recon

    With total joint replacements considered elective (with the exception for some trauma), what is your best guess when we will be returning to the field? How are companies compensating/handling their sales reps during the down time?